Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BRACCO IMAGING SPA [IT]”

19 pharma patents match "BRACCO IMAGING SPA [IT]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 19
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 19 pharmaceutical patents matching "BRACCO IMAGING SPA [IT]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

19 results for “BRACCO IMAGING SPA [IT]” · 30,257 patents in full index Clear search

  1. US 2024131199

    PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Apr 25, 2024 · Expires Apr 20, 2044

    granted

  2. KR 20240034693

    이량체 조영제의 제조

    BRACCO IMAGING SPA [IT] · Granted Mar 14, 2024 · Expires Mar 9, 2044

    granted

  3. US 2023312523

    NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Oct 5, 2023 · Expires Sep 30, 2043

    granted

  4. KR 20230116805

    가도테리돌 제조를 위한 제조 방법

    BRACCO IMAGING SPA [IT] · Granted Aug 4, 2023 · Expires Jul 30, 2043

    granted

  5. US 2023203129

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted

  6. IL 300192

    Manufacturing of dimeric contrast agents

    BRACCO IMAGING SPA [IT] · Granted Mar 1, 2023 · Expires Feb 24, 2043

    granted

  7. US 2023040008

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Feb 9, 2023 · Expires Feb 4, 2043

    granted

  8. CA 3217274

    PROCEDE DE FABRICATION D'UNE SOLUTION D'UN COMPLEXE DE GADOLINIUM

    BRACCO IMAGING SPA [IT] · Granted Feb 2, 2023 · Expires Jan 28, 2043

    granted

  9. US 2022370646

    PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Nov 24, 2022 · Expires Nov 19, 2042

    granted

  10. US 2022348923

    CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Nov 3, 2022 · Expires Oct 29, 2042

    granted

  11. US 2022062444

    PHARMACEUTICAL COMPOSITIONS COMPRISING GD-COMPLEXES AND POLYARYLENE ADDITIVES

    BRACCO IMAGING SPA [IT] · Granted Mar 3, 2022 · Expires Feb 26, 2042

    granted

  12. CA 3162611

    COMPLEXES DE FER ET SELS DE CEUX-CI UTILISES EN TANT QU'AGENTS DE CONTRASTE POUR IRM

    BRACCO IMAGING SPA [IT] · Granted Jul 29, 2021 · Expires Jul 24, 2041

    granted

  13. US 2020376145

    GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Dec 3, 2020 · Expires Nov 28, 2040

    granted

  14. IL 265680

    Dimeric contrast agents

    BRACCO IMAGING SPA [IT] · Granted May 30, 2019 · Expires May 25, 2039

    granted

  15. EP 3442949

    KONTRASTMITTEL

    BRACCO IMAGING SPA [IT] · Granted Feb 20, 2019 · Expires Feb 15, 2039

    granted

  16. US 2018362511

    DIMERIC CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Dec 20, 2018 · Expires Dec 15, 2038

    granted

  17. EP 3394627

    RATIOMETRISCH GEPULSTE CEST-BILDGEBUNG

    BRACCO IMAGING SPA [IT] · Granted Oct 31, 2018 · Expires Oct 26, 2038

    granted

  18. IL 259901

    Functionalized macrocycle chelators, complexes containing same and uses thereof as contrast agents

    BRACCO IMAGING SPA [IT] · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  19. US 2018036436

    ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT

    BRACCO IMAGING SPA [IT] · Granted Feb 8, 2018 · Expires Feb 3, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.